Paper41739293
Curcumin-mediated modulation of immunogenic cancer cell death pathways.
Moon DO. Mol Biol Rep, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Curcumin-mediated modulation of immunogenic cancer cell death pathways. Papers, record 41739293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41739293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Curcumin | Major topic |
| Immunogenic Cell Death | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Signal Transduction | |
| Animals | |
| Calreticulin | |
| HMGB1 Protein | |
| Endoplasmic Reticulum Stress | |
| Oxidative Stress | |
| Alarmins | |
| Dendritic Cells | |
| Ferroptosis |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17187072 | Calreticulin exposure dictates the immunogenicity of cancer cell death. | Nat Med | 2007 | https://conductscience.org/library/papers/17187072 | PubMed |
| 2 | 32899721 | Hsp70 and NF-kB Mediated Control of Innate Inflammatory Responses in a Canine Macrophage Cell Line. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32899721 | PubMed |
| 3 | 34298639 | Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298639 | PubMed |
| 4 | 31736963 | DAMPs and NETs in Sepsis. | Front Immunol | 2019 | https://conductscience.org/library/papers/31736963 | PubMed |
| 5 | 39061221 | The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39061221 | PubMed |
| 6 | 20192808 | HMGB1 and RAGE in inflammation and cancer. | Annu Rev Immunol | 2010 | https://conductscience.org/library/papers/20192808 | PubMed |
| 7 | 34095313 | Curcumin Targets Both Apoptosis and Necroptosis in Acidity-Tolerant Prostate Carcinoma Cells. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34095313 | PubMed |
| 8 | 27837604 | Curcumin (Turmeric) and cancer. | J BUON | 2016 | https://conductscience.org/library/papers/27837604 | PubMed |
| 9 | 39963419 | Acid-Unlocked Two-Layer Ca-Loaded Nanoplatform to Interfere With Mitochondria for Synergistic Tumor Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39963419 | PubMed |
| 10 | 40999987 | Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40999987 | PubMed |
| 11 | 16142732 | RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. | Arthritis Rheum | 2005 | https://conductscience.org/library/papers/16142732 | PubMed |
| 12 | 38126694 | Tumor Microenvironment-Specific Driven Nanoagents for Synergistic Mitochondria Damage-Related Immunogenic Cell Death and Alleviated Immunosuppression. | Small Methods | 2024 | https://conductscience.org/library/papers/38126694 | PubMed |
| 13 | 29751146 | Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma. | Arch Oral Biol | 2018 | https://conductscience.org/library/papers/29751146 | PubMed |
| 14 | 23800749 | ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. | Autophagy | 2013 | https://conductscience.org/library/papers/23800749 | PubMed |
| 15 | 31590362 | Curcumin and Cancer. | Nutrients | 2019 | https://conductscience.org/library/papers/31590362 | PubMed |
| 16 | 34006390 | The Nexus of cfDNA and Nuclease Biology. | Trends Genet | 2021 | https://conductscience.org/library/papers/34006390 | PubMed |
| 17 | 11687887 | Rac1 regulates heat shock responses by reorganization of vimentin filaments: identification using MALDI-TOF MS. | Cell Death Differ | 2001 | https://conductscience.org/library/papers/11687887 | PubMed |
| 18 | 27199984 | Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity. | Front Immunol | 2016 | https://conductscience.org/library/papers/27199984 | PubMed |
| 19 | 39349408 | NIR Enhanced pH-Responsive Microneedles for Synergetic Therapy of Melanoma. | ChemMedChem | 2025 | https://conductscience.org/library/papers/39349408 | PubMed |
| 20 | 26942057 | Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/26942057 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41739293
GET https://conductscience.org/api/papers/v1/41739293/references?page=2